2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 265.152 | 252.078 | 188.007 | 183.061 | 184.616 | 190.385 | 222.230 | 247.694 | 309.507 | 360.229 |
Total Income - EUR | 265.295 | 252.106 | 188.045 | 183.108 | 184.646 | 190.414 | 222.251 | 247.707 | 309.515 | 360.234 |
Total Expenses - EUR | 245.830 | 232.969 | 184.701 | 184.097 | 178.291 | 186.328 | 209.046 | 230.839 | 294.493 | 353.015 |
Gross Profit/Loss - EUR | 19.465 | 19.137 | 3.344 | -989 | 6.356 | 4.086 | 13.205 | 16.868 | 15.022 | 7.219 |
Net Profit/Loss - EUR | 16.351 | 16.075 | 2.781 | -2.691 | 4.509 | 2.183 | 10.983 | 14.391 | 11.927 | 3.616 |
Employees | 5 | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 5 | 5 |
Check the financial reports for the company - Farmacia Narcis Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 2.003 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 14.580 | 10.902 |
Current Assets | 122.375 | 129.089 | 124.102 | 117.419 | 120.746 | 114.828 | 121.982 | 102.368 | 109.326 | 109.946 |
Inventories | 46.494 | 48.546 | 37.145 | 36.719 | 40.247 | 43.547 | 48.792 | 46.851 | 45.412 | 46.967 |
Receivables | 42.605 | 28.846 | 16.015 | 33.480 | 39.684 | 34.496 | 46.257 | 47.602 | 56.600 | 56.777 |
Cash | 33.276 | 51.697 | 70.942 | 47.219 | 40.814 | 36.784 | 26.933 | 7.914 | 7.314 | 6.202 |
Shareholders Funds | 33.639 | 18.038 | 4.723 | 1.952 | 6.426 | 8.484 | 19.306 | 33.269 | 20.091 | 5.380 |
Social Capital | 223 | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 |
Debts | 90.739 | 111.152 | 119.379 | 115.466 | 114.320 | 106.344 | 102.677 | 69.099 | 103.814 | 115.469 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Farmacia Narcis Srl